SUPPLEMENTAL INDENTURESupplemental Indenture • January 22nd, 2015 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2015 Company Industry JurisdictionThis Supplemental Indenture (this “Supplemental Indenture”) is dated as of January 21, 2015 between Cubist Pharmaceuticals, Inc. a Delaware corporation (the “Issuer”), and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”), under the Indenture defined below.
SUPPLEMENTAL INDENTURESupplemental Indenture • January 22nd, 2015 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2015 Company Industry JurisdictionThis Supplemental Indenture (this “Supplemental Indenture”) is dated as of January 21, 2015 between Cubist Pharmaceuticals, Inc. a Delaware corporation (the “Issuer”), and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”), under the Indenture defined below.
SUPPLEMENTAL INDENTURESupplemental Indenture • January 22nd, 2015 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2015 Company Industry JurisdictionThis Supplemental Indenture (this “Supplemental Indenture”) is dated as of January 21, 2015 between Cubist Pharmaceuticals, Inc. a Delaware corporation (the “Issuer”), and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”), under the Indenture defined below.